Studied outcomes | Model | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|---|
FEV1 decline | |||||
 Cardiovascular events | Non-adjusted | 1.95 (1.74, 2.19) | 2.42 (2.16, 2.71) | 1.67 (1.48, 1.88) | Reference |
Adjusted | 1.33 (1.19, 1.49) | 1.30 (1.16, 1.46) | 1.07 (0.95, 1.21) | Reference | |
 Coronary heart disease | Non-adjusted | 2.05 (1.72, 2.44) | 2.05 (1.71, 2.45) | 1.67 (1.39, 2.00) | Reference |
Adjusted | 1.38 (1.16, 1.65) | 1.08 (0.90, 1.29) | 1.04 (0.86, 1.26) | Reference | |
 Chronic heart failure | Non-adjusted | 2.02 (1.72, 2.36) | 2.53 (2.17, 2.96) | 1.98 (1.69, 2.33) | Reference |
Adjusted | 1.47 (1.25, 1.73) | 1.39 (1.19, 1.63) | 1.33 (1.13, 1.56) | Reference | |
 Stroke | Non-adjusted | 1.94 (1.60, 2.36) | 2.49 (2.06, 3.01) | 1.65 (1.35, 2.02) | Reference |
Adjusted | 1.35 (1.11, 1.64) | 1.34 (1.10, 1.62) | 1.08 (0.88, 1.33) | Reference | |
FVC decline | |||||
 Cardiovascular events | Non-adjusted | 2.72 (2.43, 3.04) | 2.21 (1.97, 2.47) | 1.47 (1.31, 1.66) | Reference |
Adjusted | 1.28 (1.14, 1.44) | 1.15 (1.02, 1.30) | 1.06 (0.94, 1.20) | Reference | |
 Coronary heart disease | Non-adjusted | 2.89 (2.41, 3.46) | 2.42 (2.01, 2.90) | 1.74 (1.44, 2.10) | Reference |
Adjusted | 1.45 (1.20, 1.75) | 1.33 (1.10, 1.61) | 1.25 (1.03, 1.51) | Reference | |
 Chronic heart failure | Non-adjusted | 3.22 (2.77, 3.75) | 2.45 (2.10, 2.86) | 1.43 (1.21, 1.69) | Reference |
Adjusted | 1.35 (1.15, 1.58) | 1.21 (1.03, 1.42) | 1.03 (0.87, 1.22) | Reference | |
 Stroke | Non-adjusted | 2.67 (2.22, 3.22) | 2.23 (1.85, 2.69) | 1.25 (1.02, 1.53) | Reference |
Adjusted | 1.28 (1.06, 1.56) | 1.19 (0.98, 1.45) | 0.94 (0.77, 1.16) | Reference |